Published in Cancer Res on August 01, 1988
Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A (1987) 5.65
Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A (1981) 3.73
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest (1983) 2.91
Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med (1988) 2.68
Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer. J Clin Oncol (1992) 2.63
Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J Infect Dis (1988) 1.95
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res (1989) 1.86
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med (1979) 1.61
Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med (1991) 1.60
Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med (1978) 1.60
Fluorescence properties of pteridine nucleoside analogs as monomers and incorporated into oligonucleotides. Anal Biochem (1997) 1.57
The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leuk Res (1994) 1.54
A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study. Clin Cancer Res (2001) 1.49
NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology (2007) 1.47
A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid. Lab Anim Sci (1990) 1.44
Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid. J Pharmacol Exp Ther (1988) 1.43
Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors. J Natl Cancer Inst (2001) 1.43
Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood (1976) 1.40
Re: Toxicity of intrathecal melphalan. J Natl Cancer Inst (1994) 1.40
Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med (1983) 1.38
The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med (1981) 1.38
Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med (1980) 1.36
L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res (1981) 1.34
Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol (1987) 1.34
The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann Intern Med (1989) 1.33
Pregnancy outcome following cancer chemotherapy. Am J Med (1980) 1.30
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol (1996) 1.27
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. Drug Metab Dispos (1988) 1.26
Pharmacokinetics of oral methotrexate in children. Cancer Res (1983) 1.24
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. J Clin Oncol (1997) 1.18
Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected children. Antimicrob Agents Chemother (1998) 1.16
Incorporation of a fluorescent guanosine analog into oligonucleotides and its application to a real time assay for the HIV-1 integrase 3'-processing reaction. Nucleic Acids Res (1995) 1.16
Primate model for long-term study of intraventricularly or intrathecally administered drugs and intracranial pressure. Science (1977) 1.15
Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas. Neurology (2009) 1.14
Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates. Antimicrob Agents Chemother (1995) 1.14
Human T-cell antigen receptor (TCR) delta-chain locus and elements responsible for its deletion are within the TCR alpha-chain locus. Proc Natl Acad Sci U S A (1988) 1.13
Lipid peroxidation in the killing of phagocytized pneumococci. Infect Immun (1974) 1.13
Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection. J Pediatr (1989) 1.12
Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol (1988) 1.11
Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities. J Pediatr (1985) 1.11
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer (1996) 1.11
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group. Cancer Chemother Pharmacol (2006) 1.07
Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid. J Pharmacol Exp Ther (2000) 1.06
A phase I/II study of the protease inhibitor indinavir in children with HIV infection. Pediatrics (1998) 1.05
Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Cancer (1995) 1.05
Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J Clin Oncol (2000) 1.05
Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl (1998) 1.04
Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol (1985) 1.03
Adrenal suppression after short-term corticosteroid therapy. Lancet (1979) 1.02
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res (1993) 1.01
Fluorescence properties of a new guanosine analog incorporated into small oligonucleotides. Biophys J (1997) 1.01
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin Pharmacol Ther (1983) 1.00
Bacteriological isolation garment. Lancet (1974) 1.00
A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma. J Clin Oncol (1991) 1.00
Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient. J Clin Endocrinol Metab (2014) 1.00
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol (1997) 0.99
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res (1998) 0.99
Clinical pharmacokinetics of commonly used anticancer drugs. Clin Pharmacokinet (1983) 0.99
Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia. J Clin Oncol (1987) 0.99
A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer (1995) 0.98
Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N Engl J Med (1980) 0.98
Central nervous system pharmacology of antileukemic drugs. Am J Pediatr Hematol Oncol (1989) 0.98
Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics (1993) 0.97
The pharmacology of orally administered chemotherapy. A reappraisal. Cancer (1986) 0.96
Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors. Clin Cancer Res (2010) 0.96
Central nervous system leukemia. Curr Opin Oncol (1996) 0.95
Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood. J Clin Oncol (1990) 0.95
Cerebral subarachnoid sampling of cerebrospinal fluid in the rhesus monkey. Lab Anim Sci (1994) 0.95
A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid. Cancer Res (1994) 0.95
Synthesis and fluorescence characterization of pteridine adenosine nucleoside analogs for DNA incorporation. Anal Biochem (2001) 0.94
The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther (1987) 0.94
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer (1999) 0.94
Computer assisted tomography in methotrexate encephalopathy. J Comput Assist Tomogr (1977) 0.94
A primate model for study of methotrexate pharmacokinetics in the central nervous system. Cancer Res (1977) 0.93
Cytosine arabinoside cerebrospinal fluid kinetics. Clin Pharmacol Ther (1984) 0.93
Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet (1978) 0.93
Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. J Clin Invest (1978) 0.92
Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates. Antimicrob Agents Chemother (1990) 0.92
Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial. Clin Cancer Res (1999) 0.92
T cell receptor alpha-, beta-, and gamma-genes in T cell and pre-B cell acute lymphoblastic leukemia. J Clin Invest (1987) 0.92
Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies. Blood (1989) 0.92
Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. J Clin Oncol (1995) 0.92
Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey. Cancer Chemother Pharmacol (1993) 0.92